TFX vs USBC
Teleflex Incorporated (TFX) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
TFX currently screens at market cap $5.53B and trailing P/E 2082.7. USBC currently screens at market cap $0.
Not investment advice. Open the TFX and USBC stock pages for the full models.
Not investment advice.